Police have arrested a Toronto woman in connection with three recent homicides and investigators say that they believe two of the victims may have been 'randomly targeted.'
Canadian-founded company develops first AI-designed COVID-19 drug, starts clinical trials
For the first time ever, a drug for COVID-19 designed with artificial intelligence is headed to clinical trials.
Insilico Medicine, a Hong Kong-based AI pharmaceutical company, announced last Thursday its ISM3312 therapeutic would be starting clinical trials in China after its preclinical studies found that the drug "significantly reduces" viral load and inflammation in the lungs.
“Generative AI is transforming every area of human development,†Alex Zhavoronkov, Insilico's Canadian founder and CEO, . “We’re extremely happy to announce that our second small molecule therapeutic generated using generative AI is now entering human clinical trials and there is a very clear timeline to demonstrate the discovery and development cycle.â€
The drug works by inhibiting enzymes in the virus known as proteases by irreversibly binding to them. The particular protease it targets is called 3CLpro, the main protease found in the SARS-CoV-2 virus.
"The target is a great target. The beauty of it is that this protease that is targeted, it's very dissimilar of those that we in the human body actually have, so it's a good target," Oxford University's Dr. Peter Juni, former head of the Ontario Science Table, told CTV's Your Morning on Tuesday.
Insilico leveraged AI in order to develop and test a molecule that can bind and inhibit the protease by fitting into its pockets. This molecule would then become the basis of the drug.
"What AI is really good at is detecting patterns and then basically make use of these patterns to develop a drug or a molecule that fits into certain pockets," Juni explained. "AI doesn't care about our conventions that we have scientists. It just recognizes patterns and tries to find the best fit."
Currently, the drug treatment options for COVID-19 include prescription antivirals like Paxlovid and Evusheld, but Insilico researchers note that these drugs may be ineffective at treating future variants of the virus. The U.S. Food and Drug Administration has already pulled its authorization for Evusheld, citing its inefficacy in treating certain variants of COVID-19.
But similar proteases to the one that ISM3312 targets are found in all coronaviruses, meaning that the drug could be effective at not only targeting current and future variants of SARS-CoV-2, but other coronaviruses as well.
However, despite its potential, Juni says it's too early to tell if the drug will be a success.
"It's a good start but there's a long time to go until we know whether it's safe in humans, and whether it actually works," he said.
CTVNews.ca Top Stories
NDP house leader laments 'agents of chaos' in precarious Parliament
NDP House leader Peter Julian says there's more his party wants to do in Parliament before the next election, but if the current dysfunction continues it will become a factor in how they vote on a confidence measure.
Former Colorado county clerk Tina Peters sentenced to 9 years for voting data scheme
A judge ripped into a Colorado county clerk for her crimes and lies before sentencing her Thursday to nine years behind bars for a data-breach scheme spawned from the rampant false claims about voting machine fraud in the 2020 presidential race.
A northeastern Ontario jury has started deliberating in Canadian musician Jacob Hoggard's sexual assault trial, we can now tell you what they weren't allowed to hear.
A teen charged with the murder of another teen on Prince Edward Island last year has pleaded guilty to a lesser charge of manslaughter.
At least two people are dead and others are injured after a fire ripped through a century-old building in Old Montreal early Friday morning, sources told Noovo Info.
A French judge in a shocking rape case allows the public to see some of the video evidence
A French judge in the trial of dozens of men accused of raping an unconscious woman whose now former husband had repeatedly drugged her so that he and others could assault her decided on Friday to allow the public to see some of the video recordings of the alleged rapes.
Scientists looked at images from space to see how fast Antarctica is turning green. Here's what they found
Parts of icy Antarctica are turning green with plant life at an alarming rate as the region is gripped by extreme heat events, according to new research, sparking concerns about the changing landscape on this vast continent.
Canadian family stuck in Lebanon anxiously awaits flight options amid Israeli strikes
A Canadian man who is trapped in Lebanon with his family says they are anxiously waiting for seats on a flight out of the country, as a barrage of Israeli airstrikes continues.
Local Spotlight
Chantal Kreviazuk is set to return to Winnipeg to mark a major milestone in her illustrious musical career.
From the beaches of Cannes to the bustling streets of New York City, a new film by a trio of Manitoba directors has toured the international film festival circuit to much pomp and circumstance.
A husband and wife have been on the road trip of a lifetime and have decided to stop in Saskatchewan for the winter.
The grave of a previously unknown Canadian soldier has been identified as a man from Hayfield, Man. who fought in the First World War.
A group of classic car enthusiasts donated hundreds of blankets to nursing homes in Nova Scotia.
Moving into the second week of October, the eastern half of Canada can expect some brisker fall air to break down from the north
What does New Westminster's təməsew̓txʷ Aquatic and Community Centre have in common with a historic 68,000-seat stadium in Beijing, an NFL stadium and the aquatics venue for the Paris Olympics? They've all been named among the world's most beautiful sports venues for 2024.
The last living member of the legendary Vancouver Asahi baseball team, Kaye Kaminishi, died on Saturday, Sept. 28, surrounded by family. He was 102 years old.
New data from Greater Vancouver and the Fraser Valley shows a surge in supply and drop in demand in the region's historically hot real estate market.